Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1997-03-28
1998-03-31
Richter, Johann
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
548447, 548494, C07D20986, C07D40312
Patent
active
057339236
ABSTRACT:
A class of novel 1H-indole-3-glyoxylamides is disclosed together with the use of such indole compounds for inhibiting sPLA.sub.2 mediated release of fatty acids for treatment of conditions such as septic shock.
REFERENCES:
patent: 2825734 (1958-03-01), Speeter
patent: 3242163 (1966-03-01), Sarett et al.
patent: 3259622 (1966-07-01), Shen et al.
patent: 3351630 (1967-11-01), Shen
patent: 3449363 (1969-06-01), Littell
patent: 3624103 (1971-11-01), Demartilis et al.
patent: 3691194 (1972-09-01), Papanastassion
patent: 3801594 (1974-04-01), Poletto
patent: 4012513 (1977-03-01), Birchall et al.
patent: 4397850 (1983-08-01), Madelson
Jula, Marc; Igolen, Jean; and Igolen, Hanne: "Recherches en serie indolique. VI Sur quelques tryptamines substitutees"; Bul. Soc. Chem. France, 1962, pp. 1060-1068.
Romeo, E., "2-Aryl-3-Indoleglyoxylamides (FGIN-1): A New Class of Potent and Specific Ligands for the Mitochondrial DBI Receptor (MDR)", The Journal of Pharmacology and Experimental Therapeutics, vol. 262, No. 3, pp. 971-978 (1992).
Chemical Abstracts, vol. 67, 73028h, 1967, "Fragmentation of N-benzylindoles in Mass Spectrometry".
Alemany, A; Alvarez, E.; Lopez, O. and Herraez, M.E.; No. 565 -- "Inhibiteurs d' enzymes. XII-Prepartion de (propargyamino-2-ethly)-3 indoles"; Bulletin Do La Societe 'Chimiqque De France, 1974, No. 12, pp. 2883-2888.
Kollenz, Gert; Labes, Christa; "Indol-Umlagerung von 1-Diphenyl amino-2,3-dihydro-2,3-pyrrolidionen"; Liebigs Ann. Chem., 1975, pp. 1979-1983.
Kreft, A; Nelson, J. et al.; "Structure-activity relationships leadikng to WAY-121,520, a tris aryl type, Nidomethacin-based, phospholipase A2 (PLA2)/leukotriene biosynthesis inhibitor", Issue vol. 39 (1993), pp. C33-C35, ISSN 0065-4299; publ. by Birkhauser Verlag, Basel Switzerland; (Proceeding of the Sixth International Research Assoc., Sep. 20-24, 1992 at White Haven, PA/USA, Ed., D.W. Morgan and A.K. Welton.
Seilhamer, Jeffery, et al., "Cloning and Recombinant Expression of Phospholipase A.sub.2 present in Rheumatoid Arthritic Synovial Fluid"; The journal of Biological Chemistry, 254:10, Apr. 5, 1989 , 5335-5338.
Kramer, Ruther et al., "Struycture and Properties of Human Non-Pancreatic Phospholipase A2", THe Journal of Biological Chemistry 264:10, Apr. 5, 1989, pp. 5768-5775.
Reynolds, et al., "Analysis of Human Synovial Fluid Phospholipase A2 on Short Chain Phosphatidylcholine-Mixed Micelles: Development of a Spectrophotometric Assay Suitable for a Microtiterplate Reader", Analytical Biochem., 204, pp. 190-197 (1992).
Rossum, et al., "Cumulative Dose-Response Curves II. Technique for the making of dose response curves in isloated organs and the evaluation of drug parameters", Arch. Int. Pharmacodyn. 143, No. 34, pp. 299-330, 1963.
Wald, Douglas R., "Analysis of Dose-Response Relationships", Dept. of Pharma, Univ. of Mass. Med. Center, 145-179 (no date available).
Andreani, A. et al., "Nonsteroidal Antiinflammatory Agents. 2. Synthesis and Biological Activity of 2-Chlorindolecarboxylic Aicds", Journal of Medicinal Chemistry, vol. 20, No. 10, 1977, pp. 1344-1346.
Julia, Marc., et al., "No. 208-Recherches en Serie indolique. XIII. Sur quelques methoxy-5 et. -6 tryptamines", Bulletin de La Societe Chimique de France, Paris, France; 1965, pp. 1411-1417.
Chemical Abstracts, vol. 1/2, No. 24, Abstract No. 223181s; "Kinetis of hydrolysis of indomethacin and indomethacin ester predrugs in aqueous solution" Jun. 11, 1990, p. 407.
Chemical Abstracts Service. "Registry Handbook", Number Section, Registry Numbers (see, CAS RN 6264 33-1) 1965-1971, Publ. American Chemical Society.
Von K.H. Boltze; O. Brendler, et al., "Chemische Struktur and antiophlogistische Wirkung in der Reihe der substituierten Indol-3-essigsauren" Arznermittel Forschung Drug Research, vol. 30 (II), No. 8A, 1980, Aulendorf, DE, pp. 1314-1325.
Bach Nicholas J.
Dillard Robert D.
Draheim Susan E.
Benjamin Roger S.
Boone David E.
Eli Lilly and Company
Richter Johann
Sackey Ebenezer
LandOfFree
1H-indole-3-glyoxylamide sPLA.sub.2 inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 1H-indole-3-glyoxylamide sPLA.sub.2 inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 1H-indole-3-glyoxylamide sPLA.sub.2 inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-52381